Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)
Code effective Jan 01, 2017
HCPCS Section
Procedures/Professional Services (Temporary Codes)
G0429 is a valid 2026 HCPCS code meaning Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy) or (Dermal filler injection(s)) for short. HCPCS G0429 has been effective since 01/01/2017 and applies to Medical care.
|
HCPCS Level II Code Section G - Procedures/Professional Services (Temporary Codes) |
|
| HCPCS Code | G0429 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
13 - Clinical Lab Fee Schedule - Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| ASC payment group code | Effective Jan 01, 2017 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | P6A - Minor procedures - skin |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Jan 01, 2017 |
| Date added | Added Mar 23, 2010 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.